MAPT and Alzheimer disease: The apoE4 allele is the dominant genetic risk factor for late-onset AD, and apoE4 has great influence in Aβ aggregation and clearance, tau pathogenesis, neuroinflammation, synaptic dysfunction, and neuronal loss [56, 89, 147].